Authors: BOESKEN WH KULT J

Citation: Wh. Boesken et J. Kult, HIGH-DOSE TORASEMIDE, GIVEN ONCE-DAILY INTRAVENOUSLY FOR ONE WEEK, INPATIENTS WITH ADVANCED CHRONIC-RENAL-FAILURE, Clinical nephrology, 48(1), 1997, pp. 22-28

Authors: KULT J STAPF E BIAYEE DE MATATA BM MAHIOUT A

Citation: J. Kult et al., IMPROVED ELIMINATION OF LOW-MOLECULAR-WEIGHT PROTEINS WITH A NEW POLYSULFONE(R) MEMBRANE SUPERFLUX DURING HEMODIALYSIS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 823-823

Authors: KULT J BUNDSCHU HD ROMEN W

Citation: J. Kult et al., INHIBITION OF RENAL-INSUFFICIENCY PROGRES SION IN GLOMERULAR-DISEASESBY DIETARY-PROTEIN RESTRICTION AND COMBINATION THERAPY WITH ENALAPRILAND NITRENDIPINE, Nieren- und Hochdruckkrankheiten, 24(5), 1995, pp. 256-258

Authors: KULT J LARRAT V

Citation: J. Kult et V. Larrat, XIPAMIDE IN CHRONIC-RENAL-FAILURE - THERA PEUTIC EXPERIENCE, Nieren- und Hochdruckkrankheiten, 24(1), 1995, pp. 1-11

Authors: BOESKEN W KULT J KUHN A MEYERSABELLEK W PIESCHE L VANDERDOES R

Citation: W. Boesken et al., LONG-TERM SAFETY OF HIGH-DOSE ORAL TREATMENT WITH THE NEW LOOP DIURETIC TORASEMIDE IN PATIENTS WITH ADVANCED CHRONIC-RENAL-FAILURE, Kidney international, 47(3), 1995, pp. 992-992

Authors: KULT J BOESKEN W KUHN A MEYERSABELLEK W PIESCHE L

Citation: J. Kult et al., SHORT-TERM HIGH-DOSE INTRAVENOUS TREATMENT WITH THE NEW LOOP DIURETICTORASEMIDE IN PATIENTS WITH ADVANCED CHRONIC-RENAL-FAILURE, Kidney international, 47(3), 1995, pp. 992-992